Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05813587
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2023-04-10
Brief Title:
To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19
Sponsor:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Organization:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Organization Data
Organization:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
MPZ-III-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None